MedTrace Logo

Opioid Analgesic Reduction Study (OARS) - Pilot

NCT05283499 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2023-06-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.

Conditions

  • Post Operative Pain

Interventions

DRUG

OPIOID

Analgesic assignment

DRUG

NON-OPIOID

Analgesic assignment

Sponsors & Collaborators

  • University of Illinois at Chicago

    collaborator OTHER

  • University of Maryland, Baltimore

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Janine Fredericks-Younger, DMD · Rutgers School of Dental Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2021-03-12
Completion
2021-03-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05283499 on ClinicalTrials.gov